Form 4: Dentsply Sirona Executive Robert Anthony Johnson Reports Acquisition of Stock and Phantom Stock

Sentiment:

SEC Form 4


Robert Anthony Johnson, SVP and Chief Supply Chain Officer at Dentsply Sirona, reports acquiring additional restricted stock units and phantom stock due to dividend accruals.

Summary

  • On October 11, 2024, Robert Anthony Johnson, SVP, Chief Supply Chain Officer of Dentsply Sirona Inc. [XRAY], acquired 439.967 shares of common stock through dividend accruals on restricted stock units (RSUs).
  • These RSUs vest simultaneously with the underlying awards and convert to common stock on a 1:1 basis.
  • Johnson also acquired 19.073 shares of phantom stock through accrued dividends under the Supplemental Executive Retirement Plan (SERP).
  • Each share of phantom stock is the economic equivalent of one share of common stock and becomes payable in common stock upon termination of employment.
  • Following these transactions, Johnson beneficially owns 95,804.886 shares of common stock and 2,939.3174 shares of phantom stock.

Sentiment

Score: 7

Explanation: The document is a standard SEC filing detailing routine stock transactions related to executive compensation. It doesn't contain any information that would significantly impact investor sentiment positively or negatively.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency regarding the alignment of executive interests with shareholder value.

Comparison to Industry Standards

  • Executive compensation packages including RSUs and phantom stock are common across publicly listed companies, particularly in the healthcare and dental sectors.
  • Companies like Align Technology (ALGN) and Straumann (STMN.SW) also utilize similar equity-based compensation to incentivize their executives.
  • The vesting schedules and dividend accrual mechanisms are generally aligned with industry best practices to retain key personnel and reward performance.

Stakeholder Impact

  • The filing provides transparency to shareholders regarding executive compensation and alignment of interests.
  • Employees may be interested in the details of the SERP and RSU programs.

Key Dates

DateDescription
10/11/2024Date of transaction for common stock and phantom stock acquisition.
10/15/2024Date of signature by Attorney-In-Fact.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.